Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KYMR)

CUSIP: 501575104

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+9,115,698
Put/Call ratio
198%
SEC-reported price per share
$77.81
Number of holders
254
Value change
+$715,972,868
Number of buys
156
Open additional details 1 more signal available
Number of sells
79
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
83,129,381

Security key

501575104

Report period

Q4 2025

Institutions

254

Top holders

10

Ownership snapshot

Top reported holders of KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
09 Dec 2025
13D/G 13F Lead comparable stake: 11% 13D/G row: BAKER BROS. ADVISORS LP Showing 1-6 of 15 holder rows.

Quick read

BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership Top 5
BAKER BROS. ADVISORS LP 11%
PRICE T ROWE ASSOCIATES INC /MD/ 7.1%
BlackRock, Inc. 5.4%
Avoro Capital Advisors LLC 7.6%
FMR LLC 7.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
13D/G 13F
Company
11%
$551,236,913
8,676,797 shares
+$127,711,627 09 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
7.1%
$288,530,046
5,097,704 shares
$0 30 Sep 2025
BlackRock, Inc.
13F 13D/G
Company
5.4%
from 13D/G
$247,084,359
4,365,448 shares
30 Sep 2025
Avoro Capital Advisors LLC
13F
Company
13F
7.6%
$359,410,000
6,350,000 shares
30 Sep 2025
FMR LLC
13F
Company
13F
7.1%
$332,785,989
5,879,611 shares
30 Sep 2025
BVF INC/IL
13F
Company
13F
6.6%
$311,453,386
5,502,710 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
254
Shares
89,844,621
Rows available
254
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
207
Q4 2025 holders
254
Holder diff
47
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .